BONUS The Path with Becky Quick: Head of the Class 3/20/26

<p>Baby KJ was a pioneer before he was even a year old. Born in 2024 with a rare, life-threatening genetic mutation, Nicole and Kyle Muldoon’s son is the world’s first patient to receive successful personalized gene editing therapy. Doctors at the Children’s Hospital of Philadelphia (<a href="https://www.chop.edu/centers-programs/genetherapy4inheritedmetabolicdisorders/future-personalized-medicine-here-kjs" rel="noopener noreferrer">CHOP</a>) and Penn Medicine collaborated to create a unique drug just for KJ, to treat his disorder known as severe carbamoyl phosphate synthetase 1 (CPS1) deficiency. After spending the first months of …